HER2-positive Advanced Breast Cancer
Also known as: HER-2-positive Advanced Breast Cancer / Advanced HER2-positive Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00072 | Trastuzumab | 1 | Completed | 1 |
| DB11652 | Tucatinib | 1 | Completed | 1 |
| DB11881 | AUY922 | 1 / 2 | Completed | 1 |
| DB00072 | Trastuzumab | 1 / 2 | Completed | 1 |
| DB00361 | Vinorelbine | 2 | Completed | 1 |
| DB01101 | Capecitabine | 3 | Not Yet Recruiting | 1 |
| DB01101 | Capecitabine | 3 | Unknown Status | 2 |
| DB17212 | DP-303c | 3 | Not Yet Recruiting | 1 |
| DB01259 | Lapatinib | 3 | Unknown Status | 1 |
| DB00072 | Trastuzumab | 3 | Not Yet Recruiting | 1 |
| DB00361 | Vinorelbine | 3 | Not Yet Recruiting | 1 |
| DB17457 | Inetetamab | Not Available | Not Yet Recruiting | 1 |
| DB17457 | Inetetamab | Not Available | Recruiting | 1 |
| DB14993 | Pyrotinib | Not Available | Recruiting | 1 |
| DB00361 | Vinorelbine | Not Available | Recruiting | 1 |